Cargando…

CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)

Primary Amoebic Meningoencephalitis (PAM) is caused by Naegleria fowleri, a free-living amoeba that occasionally infects humans. While considered “rare” (but likely underreported) the high mortality rate and lack of established success in treatment makes PAM a particularly devastating infection. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debnath, Anjan, Calvet, Claudia M., Jennings, Gareth, Zhou, Wenxu, Aksenov, Alexander, Luth, Madeline R., Abagyan, Ruben, Nes, W. David, McKerrow, James H., Podust, Larissa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746216/ https://www.ncbi.nlm.nih.gov/pubmed/29284029 http://dx.doi.org/10.1371/journal.pntd.0006104

Ejemplares similares

Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
por: Chen, Chiung-Kuang, et al.
Publicado: (2010)

Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51
por: Gunatilleke, Shamila S., et al.
Publicado: (2012)

Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit
por: Chen, Chiung-Kuang, et al.
Publicado: (2009)

Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri
por: Zhou, Wenxu, et al.
Publicado: (2018)

Primary amoebic meningoencephalitis
por: Shrestha, Gentle Sunder, et al.
Publicado: (2015)

Binding Mode and Potency of N-Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51
por: Vieira, Debora F., et al.
Publicado: (2014)

Antineoplastic kinase inhibitors: A new class of potent anti-amoebic compounds
por: Sauvey, Conall, et al.
Publicado: (2021)

4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency
por: Calvet, Claudia M., et al.
Publicado: (2014)

Primary Amoebic Meningoencephalitis in an Iranian Infant
por: Movahedi, Zahra, et al.
Publicado: (2012)

Drug Strategies Targeting CYP51 in Neglected Tropical Diseases
por: Choi, Jun Yong, et al.
Publicado: (2014)

A Fatal Case of Primary Amoebic Meningoencephalitis (PAM) Complicated with Diabetes Insipidus (DI): A Case Report and Review of the Literature
por: Mushtaq, Muhammad Zain, et al.
Publicado: (2020)

Lethal encounters: The evolving spectrum of amoebic meningoencephalitis
por: Gompf, Sandra G., et al.
Publicado: (2019)

Editorial: Drug Development for Parasite-Induced Diarrheal Diseases
por: Debnath, Anjan, et al.
Publicado: (2017)

Primary Amoebic Meningoencephalitis in an Infant due to Naegleria fowleri
por: Khanna, Vinay, et al.
Publicado: (2011)

Primary Amoebic Meningoencephalitis by Naegleria fowleri: Pathogenesis and Treatments
por: Güémez, Andrea, et al.
Publicado: (2021)

Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment
por: Chao-Pellicer, Javier, et al.
Publicado: (2023)

4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection
por: Calvet, Claudia Magalhaes, et al.
Publicado: (2017)

Case Report and Literature Review: Bacterial Meningoencephalitis or Not? Naegleria fowleri Related Primary Amoebic Meningoencephalitis in China
por: Zhou, Wenjuan, et al.
Publicado: (2022)

A Fatal Case of Primary Amoebic Meningoencephalitis from Recreational Waters
por: Hamaty, Edward, et al.
Publicado: (2020)

Fatal primary amoebic meningoencephalitis in a Norwegian tourist returning from Thailand
por: Stubhaug, Tore Taksdal, et al.
Publicado: (2016)

A case report: primary amoebic meningoencephalitis in a young Zambian adult
por: Chomba, Mashina, et al.
Publicado: (2017)

A Japanese case of amoebic meningoencephalitis initially diagnosed by cerebrospinal fluid cytology
por: Aoki, Ryogo, et al.
Publicado: (2020)

Metagenomics-driven rapid diagnosis of an imported fatal case of rare amoebic meningoencephalitis
por: Guan, Qingtian, et al.
Publicado: (2021)

Primary Amoebic Meningoencephalitis Caused by Naegleria fowleri: An Old Enemy Presenting New Challenges
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2014)

Successful treatment of a case of primary amoebic meningoencephalitis: How important is history taking
por: Sharma, Avinash, et al.
Publicado: (2015)

Inhibition of Fatty Acid Oxidation as a New Target To Treat Primary Amoebic Meningoencephalitis
por: Sarink, Maarten J., et al.
Publicado: (2020)

Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
por: Che, Xiujuan, et al.
Publicado: (2023)

Genetic Detection of Amoebic Meningoencephalitis Causing by Naegleria Fowleri in Iraq: A Case Report
por: Baqer, Noor Nihad, et al.
Publicado: (2023)

Heat shock protein 90 inhibitors repurposed against Entamoeba histolytica
por: Shahinas, Dea, et al.
Publicado: (2015)

Clinical manifestations and outcome of patients with primary amoebic meningoencephalitis in Pakistan. A single-center experience
por: Rehman, Shakeel Ur, et al.
Publicado: (2023)

A case of Naegleria fowleri related primary amoebic meningoencephalitis in China diagnosed by next-generation sequencing
por: Wang, Qiang, et al.
Publicado: (2018)

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri
por: Debnath, Anjan, et al.
Publicado: (2018)

Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa
por: Warrilow, Andrew G. S., et al.
Publicado: (2016)

High-throughput phenotypic screen identifies a new family of potent anti-amoebic compounds
por: Sauvey, Conall, et al.
Publicado: (2023)

A pediatric case of primary amoebic meningoencephalitis due to Naegleria fowleri diagnosed by next-generation sequencing of cerebrospinal fluid and blood samples
por: Huang, Shiqin, et al.
Publicado: (2021)

Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target
por: Long, Thavy, et al.
Publicado: (2017)

Amœbic Dysentery
Publicado: (1892)

Amœbic Dysentery
por: Hardikar, S. W.
Publicado: (1943)

Amoebic Dysentery
Publicado: (1907)

Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity
por: Franco, Caio H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_37vvcs4ufl6ipkae1lcfs3ep0a